Palatin Technologies, Inc. (PTNT)
OTCMKTS · Delayed Price · Currency is USD
8.59
-0.16 (-1.85%)
At close: Sep 11, 2025
Palatin Technologies Employees
Palatin Technologies had 30 employees as of June 30, 2024. The number of employees decreased by 4 or -11.76% compared to the previous year.
Employees
30
Change (1Y)
-4
Growth (1Y)
-11.76%
Revenue / Employee
$11,667
Profits / Employee
-$777,599
Market Cap
8.35M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 30 | -4 | -11.76% |
| Jun 30, 2023 | 34 | 1 | 3.03% |
| Jun 30, 2022 | 33 | 7 | 26.92% |
| Jun 30, 2021 | 26 | 6 | 30.00% |
| Jun 30, 2020 | 20 | 2 | 11.11% |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Elite Pharmaceuticals | 68 |
| Tian'an Technology Group | 8 |
| Glass House Brands | 374 |
| CytoDyn | 13 |
| Northwest Biotherapeutics | 25 |
| American Oncology Network | 1,914 |
| Silence Therapeutics | 116 |
| Jushi Holdings | 1,234 |
Palatin Technologies News
- 24 days ago - Boehringer Ingelheim and Palatin Technologies to develop potential first-in-class melanocortin receptor targeted treatment for patients with retinal diseases - GlobeNewsWire
- 4 weeks ago - Palatin Announces 1-for-50 Reverse Stock Split - PRNewsWire
- 2 months ago - Palatin Announces Positive Preclinical Efficacy Data for Oral MC4R Agonist PL7737 in Animal Model of Obesity - PRNewsWire
- 4 months ago - Palatin Technologies, Inc. (PTN) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Palatin Reports Fiscal Year 2025 Third Quarter Results and Business Update - PRNewsWire
- 4 months ago - Palatin Presents Promising Preclinical Data on Melanocortin Agonists for Retinopathy at ARVO 2025 - PRNewsWire
- 4 months ago - Palatin Technologies Announces Closing of Reduced Public Offering - PRNewsWire
- 4 months ago - Palatin Technologies Announces Transition to OTC Pink Following NYSE American Delisting Notice - PRNewsWire